USD 1.12 billion
Venous Thromboembolism Treatment Market Size, Share, Growth Analysis, By Device(Compression System, Thrombectomy Systems, IVC Filters, Stockings), By Application(Deep vein Thrombosis, Pulmonary Embolism), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35D2196 |
Region:
Global |
Published Date: April, 2024
Pages:
219
|Tables:
64
|Figures:
75
Venous Thromboembolism Treatment Market Insights
Global Venous Thromboembolism Treatment Market size was valued at USD 1.12 billion in 2022 and is poised to grow from USD 1.22 billion in 2023 to USD 2.37 million by 2031, growing at a CAGR of 8.7% in the forecast period (2024-2031).
The venous thromboembolism (VTE) treatment market addresses a vital scientific condition characterized with the aid of the formation of blood clots inside the veins, which could result in probably life-threatening headaches like pulmonary embolism or deep vein thrombosis. VTE is a good sized global health concern, and the market revolves around treatment options and interventions to save you, manipulate, and treat this condition.
Several factors power the dynamics of the VTE remedy marketplace. Firstly, the growing incidence of VTE cases, regularly related to sedentary life, getting older populations, and surgical strategies, fuels the call for effective remedies. Secondly, ongoing advancements in anticoagulant medicines, including direct oral anticoagulants (DOACs) and injectable therapies, offer progressed treatment options with decreased bleeding dangers compared to traditional treatment plans like warfarin.
Additionally, the increasing awareness of VTE threat elements and the significance of early prognosis and remedy is driving market increase. Moreover, the adoption of novel treatment plans and preventive measures, together with mechanical compression devices and filters, contributes to the growth of the VTE treatment market.
However, demanding situations exist in coping with VTE, along with the want for personalized remedy plans, ensuring affected person compliance, and addressing the hazard of bleeding headaches associated with anticoagulants. As the burden of VTE keeps to upward thrust, the VTE treatment marketplace stays essential in presenting existence-saving interventions and treatment plans to sufferers at risk of or affected by this condition.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Anticoagulants
Fastest Growth
Anticoagulants
Growth Rate
8.7% CAGR
Global Venous Thromboembolism Treatment Market ($ Bn)
Country Share for U.S Region (%)
To get more reports on the above market click here to Buy The Report
Venous Thromboembolism Treatment Market Segmental Analysis
The Venous Thromboembolism Treatment Market is segmented by Device, Application, End-use, and Region. Based on Device the market is segmented as, Compression System, Thrombectomy Systems, IVC Filters, Stockings, Others. Based on Application the market is segmented as, Deep vein Thrombosis, Pulmonary Embolism. Based on End-use the market is segmented as, Hospitals, Catheterization Laboratories, Others. Regional the market is segmented as, North America, Europe, Asia-Pacific, and Latin America
Analysis By Device
In the Venous Thromboembolism (VTE) treatment market, the "Anticoagulants" segment is the dominating force, representing the most commonly used approach for managing VTE. Anticoagulants, such as heparin and warfarin, are medications that prevent blood clots from forming or getting larger. They are broadly prescribed for both the initial treatment and lengthy-time period prevention of VTE, making this segment the cornerstone of VTE management.The well-established use of anticoagulants, along with their effectiveness and versatility, contributes to their dominance in the market.
On the other hand, the "Thrombectomy Systems" phase is the quickest-developing segment inside the VTE treatment marketplace. Thrombectomy systems are medical devices designed to physically do away with blood clots from veins, providing a minimally invasive opportunity to conventional anticoagulant therapy. This phase's rapid boom can be attributed to advancements in thrombectomy technology, increasing adoption by means of healthcare specialists, and the growing reputation of the importance of well timed clot removal, especially in instances of acute VTE. As greater healthcare providers integrate thrombectomy systems into their remedy protocols, this section is predicted to witness increased enlargement within the VTE remedy marketplace.
Analysis By Application
In the Venous Thromboembolism (VTE) remedy marketplace, the "Deep Vein Thrombosis (DVT)" section is presently dominating the marketplace. DVT is a commonplace and probably severe scientific circumstance wherein blood clots shape in deep veins, frequently in the legs. Given the prevalence of DVT and its related risks, it has garnered widespread attention in the clinical discipline. As a result, remedies for DVT, inclusive of anticoagulants and other healing interventions, constitute a considerable part of the VTE remedy marketplace.
On the other hand, the "Pulmonary Embolism (PE)" phase is the fastest-developing within the VTE treatment market. PE takes place whilst a blood clot, typically from the legs, travels to the lungs, probably inflicting existence-threatening headaches. With increasing recognition, advanced diagnostic strategies, and advancements in treatment alternatives, the point of interest on PE control has intensified. Medical practitioners are placing greater emphasis on early detection and powerful remedies of PE, riding the increase of this phase inside the VTE remedy marketplace. As medical understanding and generation retain to adapt, advancements in PE treatment are anticipated to contribute considerably to the market's growth.
Global venous thromboembolism treatment market By Device
To get detailed analysis on other segments, Request For Free Sample Report
Venous Thromboembolism Treatment Market Regional Insights
North America stands as the biggest location within the international Venous Thromboembolism (VTE) treatment market, with america leading the manner because the dominant usa in the location. The excessive occurrence of VTE cases inside the United States, coupled with the superior healthcare infrastructure, drives the market's prominence. The country's healthcare system places huge emphasis on VTE prevention and remedy, with pointers and protocols in location to control and decrease the risks associated with this situation. Additionally, the presence of key pharmaceutical companies and research establishments contributes to the vicinity's leadership in VTE treatment.
Europe represents the second-largest area inside the VTE remedy market, with Germany rising as a distinguished participant. Germany's healthcare area is thought for its strong method to VTE management, and the country has a nicely-set up pharmaceutical enterprise that caters to the desires of VTE sufferers. European countries, which includes France and the UK, additionally play vast roles in advancing VTE treatment alternatives and studies. Both North America and Europe preserve cognizance on VTE prevention and control, with ongoing traits in treatment modalities and anticoagulant cures.
Global venous thromboembolism treatment market By Region
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Venous Thromboembolism Treatment Market Dynamics
Drivers
Rising Incidence of VTE:
- The increasing occurrence of Venous Thromboembolism (VTE) cases, driven by using factors inclusive of getting older populations, sedentary existence, and put-up-surgical operation risks, is an extensive motive force of the marketplace. As VTE poses critical health risks, its detection and remedy have gained precedence.
Advancements in Diagnosis:
- Improved diagnostic techniques, consisting of imaging technologies and biomarker assays, have more advantageous the early detection of VTE instances. Early prognosis permits for well timed intervention, lowering the chance of headaches and riding the demand for VTE remedies.
Restraints
Complex Treatment Regimens:
- Managing VTE often calls for complicated and long-time period treatment regimens, which can result in affected persons non-compliance and impact treatment results.
Generic Competition:
- The entry of time-honored versions of anticoagulant tablets can result in charge competition and doubtlessly impact the sales of branded medicines inside the marketplace.
Request Free Customization of this report to help us to meet your business objectives.
Venous Thromboembolism Treatment Market Competitive Landscape
The aggressive panorama of the Venous Thromboembolism (VTE) treatment marketplace is characterized with the aid of the presence of numerous pharmaceutical organizations and healthcare establishments striving to expand and market progressive healing procedures and interventions for VTE control. Key players in this market consist of installed pharmaceutical giants which include Pfizer Inc., Bayer AG, and Bristol-Myers Squibb Company, supplying a number of anticoagulant drugs. Furthermore, there's a developing recognition of studies and improvement via rising biotechnology firms, fostering innovation in VTE treatment methods. Collaboration and partnerships between pharmaceutical companies and healthcare businesses are commonplace, aiming to enhance the efficacy and accessibility of VTE remedies. This aggressive panorama is dynamic, driven by the continuous improvement of novel healing marketers and the enlargement of remedy alternatives for VTE patients.
Top Player’s Company Profile
- Pfizer Inc.
- Bristol-Myers Squibb Company
- Boehringer Ingelheim International GmbH
- Johnson & Johnson
- Sanofi
- Daiichi Sankyo Company, Limited
- Aspen Pharmacare Holdings Limited
- Portola Pharmaceuticals, Inc. (Now part of Alexion Pharmaceuticals, Inc.)
- GlaxoSmithKline plc
- Novartis AG
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V. (Now part of Viatris Inc.)
- Abbott Laboratories
- Biogenics Inc.
- Pfizer (Ireland) Pharmaceuticals
- CSL Limited
- Mitsubishi Tanabe Pharma Corporation
- Roche Holding AG
Recent Developments
- In November 2023, LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), a severe form of peripheral artery disease (PAD), announced that it has entered into a definitive agreement to be acquired by Inari Medical, a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases.
- In June 2023, medical device company Inari Medical launched two new purpose-built thrombectomy catheters to address the needs of venous stent thrombosis and venous thromboembolism (VTE).
Venous Thromboembolism Treatment Key Market Trends
- Rise in Direct Oral Anticoagulants (DOACs): There is a notable shift towards the use of DOACs in VTE treatment.These newer oral anticoagulants, such as apixaban, rivaroxaban, and edoxaban, are increasingly preferred over traditional warfarin due to their convenience, reduced monitoring requirements, and similar or superior efficacy in preventing and treating VTE.
- Extended Thromboprophylaxis: With a growing emphasis on VTE prevention, especially in high-risk patients after major surgeries or hospitalization, extended thromboprophylaxis is gaining prominence. This trend involves prolonged use of anticoagulants to prevent VTE recurrence.
Venous Thromboembolism Treatment Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Component type’s team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our global venous thromboembolism treatment market analysis; the global Venous Thromboembolism (VTE) treatment market is a critical component of healthcare, addressing the management of a condition characterized by the formation of blood clots in deep veins, known as VTE. The market spans various regions, with North America and Europe being the prominent ones. It is segmented into two primary applications: Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) treatments. Key drivers fueling the VTE treatment market include the rising incidence of VTE cases, especially among aging populations, as well as advancements in diagnostic technologies leading to early detection. Growing awareness about VTE risks and prevention measures has also driven market growth. Additionally, the development of innovative therapies and anticoagulants enhances the effectiveness and safety of VTE treatment. As healthcare systems and pharmaceutical companies continue to focus on VTE management and research, the market is expected to evolve further, ensuring better outcomes for patients and reducing the risks associated with this potentially life-threatening condition.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 1.12 billion |
| Market size value in 2031 | USD 2.37 million |
| Growth Rate | 8.7% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Venous Thromboembolism Treatment Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Venous Thromboembolism Treatment Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Venous Thromboembolism Treatment Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Venous Thromboembolism Treatment Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Venous Thromboembolism Treatment Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Venous Thromboembolism Treatment Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
